RFK Jr. pledged transparency, but some info remains hidden

Category	Detail
Condition	Federal public health information transparency and data availability
Key Mechanisms	Delays, deletions, and cessation of federal health data reporting and website content; agency layoffs; policy shifts affecting data collection priorities
Target Population	General U.S. population, including subgroups such as LGBTQ youth, abortion patients, overdose victims, smokers, and food safety stakeholders
Care Setting	Federal public health agencies and associated research and policy environments

Significant delays and removal of federal health data and reports across multiple domains including abortion, overdose, smoking, food safety, and LGBTQ health.
Layoffs and policy changes under the Trump administration and Health Secretary RFK Jr. have reduced data collection, reporting, and public education campaigns.
Transparency efforts claimed by HHS contrast with external expert concerns about reduced data availability and incomplete disclosure of conflicts of interest.

Maintain consistent and timely collection and reporting of health surveillance data to inform public health diagnosis and response.

Sustain public health education campaigns and data-driven interventions for issues such as smoking cessation and overdose prevention.
Ensure federal health agencies allocate adequate resources and staffing to support comprehensive data analysis and dissemination.

Continue active surveillance of key health indicators including abortion statistics, drug overdose trends, tobacco use, foodborne illnesses, and LGBTQ health metrics.
Preserve transparency in advisory committee membership and conflict of interest disclosures.

Reduced data availability impairs public health monitoring and response capabilities.
Lack of transparency and incomplete conflict of interest disclosures may undermine public trust in health agencies.
Policy-driven data suppression risks neglecting vulnerable populations and emerging health threats.

Not applicable; article focuses on public health data transparency rather than individual patient prescribing.

N/A

Ensure uninterrupted and comprehensive public health data collection and reporting to support evidence-based policy and clinical decision-making.
Maintain transparency in federal health agency operations, including timely release of reports and full disclosure of advisory committee conflicts of interest.
Protect and prioritize data collection on vulnerable populations to guide targeted health interventions and resource allocation.

Clinical Scorecard: RFK Jr. Promised Openness, Yet Certain Information Remains Concealed